Stride Analyst Price Targets

Wall Street analyst price targets and consensus rating for Stride (LRN).

Price Target Range — 12 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$102Upside to Avg. PT+30.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 23, 2026	Barrington Research	Alexander Paris	PT Cut	Outperform	$125→$115
Oct 5, 2026	BMO Capital	Jeffrey Silber	PT Cut	Market Perform	$93→$90
Apr 16, 2026	Barrington Research	Alexander Paris	Maintained	Outperform	$125
Jan 28, 2026	Canaccord Genuity	Jason Tilchen	Maintained	Buy	$125
Jan 28, 2026	Barrington Research	Alexander Paris	Maintained	Outperform	$125
Jan 21, 2026	Barrington Research	Alexander Paris	Maintained	Outperform	$125
Dec 17, 2025	Morgan Stanley	Greg Parrish	PT Cut	Equal-Weight	$130→$95
Nov 7, 2025	BMO Capital	Jeffrey Silber	PT Cut	Market Perform	$108→$82
Oct 29, 2025	Canaccord Genuity	Jason Tilchen	PT Cut	Buy	$175→$125
Oct 29, 2025	Barrington Research	Alexander Paris	PT Cut	Outperform	$185→$125
Oct 29, 2025	BMO Capital	Jeffrey Silber	Downgrade	Outperform→Market Perform	$164→$108
Oct 24, 2025	Canaccord Genuity	Jason Tilchen	PT Raise	Buy	$165→$175
Sep 23, 2025	Barrington Research	Alexander Paris	Maintained	Outperform	$185
Aug 29, 2025	Barrington Research	Alexander Paris	PT Raise	Outperform	$170→$185
Aug 6, 2025	Morgan Stanley	Greg Parrish	PT Raise	Equal-Weight	$148→$159
Jul 24, 2025	Barrington Research	Alexander Paris	Maintained	Outperform	$170
May 1, 2025	BMO Capital	Jeffrey Silber	PT Raise	Outperform	$139→$161
Apr 30, 2025	Barrington Research	Alexander Paris	PT Raise	Outperform	$150→$170
Apr 28, 2025	Canaccord Genuity	Jason Tilchen	PT Raise	Buy	$145→$155
Apr 17, 2025	Barrington Research	Alexander Paris	PT Raise	Outperform	$140→$150

Analyst Ratings News

PRO
Barrington Research Maintains Outperform on Stride, Lowers Price Target to $115

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $125 to $115.

Benzinga Newsdesk

PRO
BMO Capital Maintains Market Perform on Stride, Lowers Price Target to $90

BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:LRN) with a Market Perform and lowers the price target from $93 to $90.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Stride, Maintains $125 Price Target

Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and maintains $125 price target.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $125 price target.

Benzinga Newsdesk

A Glimpse Into The Expert Outlook On Stride Through 7 Analysts

Benzinga Insights

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $125 price target.

Benzinga Newsdesk

Stride Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Stride Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barrington Research Maintains Outperform on Stride, Lowers Price Target to $115

PRO
BMO Capital Maintains Market Perform on Stride, Lowers Price Target to $90

PRO
Canaccord Genuity Maintains Buy on Stride, Maintains $125 Price Target

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target

A Glimpse Into The Expert Outlook On Stride Through 7 Analysts

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target

People Also Watch

People Also Watch

Stride Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Stride Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarrington Research Maintains Outperform on Stride, Lowers Price Target to $115

PROBMO Capital Maintains Market Perform on Stride, Lowers Price Target to $90

PROCanaccord Genuity Maintains Buy on Stride, Maintains $125 Price Target

PROBarrington Research Maintains Outperform on Stride, Maintains $125 Price Target

A Glimpse Into The Expert Outlook On Stride Through 7 Analysts

PROBarrington Research Maintains Outperform on Stride, Maintains $125 Price Target

People Also Watch

People Also Watch

PRO
Barrington Research Maintains Outperform on Stride, Lowers Price Target to $115

PRO
BMO Capital Maintains Market Perform on Stride, Lowers Price Target to $90

PRO
Canaccord Genuity Maintains Buy on Stride, Maintains $125 Price Target

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target

PRO
Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target